Allergen activates peripheral blood eosinophil nuclear factor-κB to generate granulocyte macrophage-colony stimulating factor, tumour necrosis factor-α and interleukin-8

Clinical and Experimental Allergy

Volumn 34, Issue 7, 2004, Pages 1071-1078

  Coward, W R ^a,b   Sagara, H ^a,c   Wilson, S J ^a   Holgate, S T ^a   Church, M K ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Eosinophil; GM CSF; Human; NF B; TNF and IL 8

Indexed keywords

ALLERGEN; CALPASTATIN; GLIOTOXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PENTOXIFYLLINE; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA;

CELL ACTIVATION; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES; EOSINOPHIL; GEL MOBILITY SHIFT ASSAY; HOUSE DUST; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SEDIMENTATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANTIGENS, DERMATOPHAGOIDES; CASE-CONTROL STUDIES; CELL NUCLEUS; CELLS, CULTURED; CYTOKINES; EOSINOPHILS; GLIOTOXIN; GLYCOPROTEINS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; I-KAPPA B PROTEINS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; MICROSCOPY, CONFOCAL; NF-KAPPA B; PENTOXIFYLLINE; PROLINE; THIOCARBAMATES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3242745070     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.02003.x     Document Type: Conference Paper

References (34)

1. Kaminuma O, Mori A, Ogawa K et al. Successful transfer of late phase eosinophil infiltration in the lung by infusion of helper T cell clones. Am J Respir Cell Mol Biol 1997; 16:448-54.
2. Cowburn AS, Holgate ST, Sampson AP. IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils. J Immunol 1999; 163:456-65.
3. Lamkhioued B, Aldebert D, Gounni AS et al. Synthesis of cytokines by eosinophils and their regulation. Int Arch Allergy Immunol 1995; 107:122-3.
4. Moqbel R, Ying S, Barkans J et al. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol 1995; 155:4939-47.
5. Beg AA, Baldwin AS, Jr. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev 1993; 7:2064-70.
6. Ghosh S, May MJ, Kopp EB. NF-kappa B and rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16:225-60.
7. Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA, Baldwin AS, Jr. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev 1992; 6:1899-913.
8. Baldwin AS. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14:649-81.
9. DiDonato JA, Mercurio F, Karin M. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol Cell Biol 1995; 15:1302-11.
10. Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D, Hay RT. Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol Cell Biol 1995; 15:2689-96.
11. Hansel TT, De Vries IJ, Iff T et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991; 145:105-10.
12. Wilson SJ, Leone BA, Anderson D, Manning A, Holgate ST. Immunohistochemical analysis of the activation of NF-kappa B and expression of associated cytokines and adhesion molecules in human models of allergic inflammation. J Pathol 1999; 189:265-72.
13. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11:1475-89.
14. Capron M. [Eosinophils: protection or pathology: a cell with two personalities]. Ann Pharm Fr 1998; 56:97-101.
15. Shimokawa T, Tsuge T, Okumura K, Ra C. Identification and characterization of the promoter for the gene encoding the human myeloid IgA Fc receptor (FcalphaR, CD89). Immunogenetics 2000; 51:945-54.
16. Coward WR, Okayama Y, Sagara H, Wilson SJ, Holgate ST, Church MK. NF-kappaB and TNF-alpha: a positive autocrine loop in human lung mast cells? J Immunol 2002; 169:5287-93.
17. Capron M, Spiegelberg HL, Prin L et al. Role of IgE receptors in effector functions of human eosinophils. J Immunol 1984; 132:462-8.
18. Fukuda T, Dunnette SL, Reed CE, Ackerman SJ, Peters MS, Gleich GJ. Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma. Am Rev Respir Dis 1985; 132:981-5.
19. Traenckner EB, Wilk S, Baeuerle PA. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J 1994; 13:5433-41.
20. Yamashita N, Koizumi H, Murata M, Mano K, Ohta K. Nuclear factor kappa B mediates interleukin-8 production in eosinophils. Int Arch Allergy Immunol 1999; 120:230-6.
21. Takeno S, Hirakawa K, Ueda T, Furukido K, Osada R, Yajin K. Nuclear factor-kappa B activation in the nasal polyp epithelium: relationship to local cytokine gene expression. Laryngoscope 2002; 112:53-8.
22. Levi-Schaffer F, Lacy P, Severs NJ et al. Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. Blood 1995; 85: 2579-86.
23. Beil WJ, Weller PF, Tzizik DM, Galli SJ, Dvorak AM. Ultrastructural immunogold localization of tumor necrosis factor-alpha to the matrix compartment of eosinophil secondary granules in patients with idiopathic hypereosinophilic syndrome. J Histochem Cytochem 1993; 41:1611-5.
24. Finotto S, Ohno I, Marshall JS et al. TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol 1994; 153:2278-89.
25. Nakajima H, Gleich GJ, Kita H. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol 1996; 156:4859-66.
26. Biswas DK, Ahlers CM, Dezube BJ, Pardee AB. Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression. Mol Med 1994; 1:31-43.
27. Kim SH, Han SI, Oh SY, Chung HY, Kim HD, Kang HS. Activation of heat shock factor 1 by pyrrolidine dithiocarbamate is mediated by its activities as pro-oxidant and thiol modulator. Biochem Biophys Res Commun 2001; 281:367-72.
28. Pahl HL, Krauss B, Schulze-Osthoff K et al. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J Exp Med 1996; 183:1829-40.
29. Roebuck KA. Regulation of interleukin-8 gene expression. J Interferon Cytokine Res 1999; 19:429-38.
30. Palanki MS. Inhibitors of AP-1 and NF-kappa B mediated transcriptional activation: therapeutic potential in autoimmune diseases and structural diversity. Curr Med Chem 2002; 9: 219-27.
31. Adcock IM, Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol 2001; 79:376-84.
32. Park HS, Jung KS, Shute J, Roberts K, Holgate ST, Djukanovic R. Allergen-induced release of GM-CSF and IL-8 in vitro by nasal polyp tissue from atopic subjects prolongs eosinophil survival. Eur Respir J 1997; 10:1476-82.
33. Temkin V, Levi-Schaffer F. Mechanism of tumour necrosis factor alpha mediated eosinophil survival. Cytokine 2001; 15:20-6.
34. Shute JK, Tenor H, Church MK, Holgate ST. Theophylline inhibits the release of eosinophil survival cytokines - is Raf-1 the protein kinase A target? Clin Exp Allergy 1998; 28:47-52.